Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 20-Mar-18 1:08 PM View:  | Campbell Vyvyan Director | Petlife Pharmaceuticals, Inc. (PTLF) | 28-Feb-18 | Purchase | 305,000 | $4,017.00 | $1,225,190,016.00 | 31% 1000.0K to 1.3M | |
| 02-Mar-18 3:00 PM View: | Vivek Ramana Chief Medical Officer | Petlife Pharmaceuticals, Inc. (PTLF) | 17-Aug-17 | Disposition (other) | 1,000,000 | -- | -- | (33%) 3.0M to 2.0M | |
| 02-Mar-18 3:00 PM View: | Salvagno Ralph T Chief Executive Officer Director 10% Owner | Petlife Pharmaceuticals, Inc. (PTLF) | 17-Aug-17 | Acquisition (other) | 1,250,000 | -- | -- | 7% 18.7M to 19.95M | |
| 02-Mar-18 3:00 PM View: | Salvagno Ralph T Chief Executive Officer Director 10% Owner | Petlife Pharmaceuticals, Inc. (PTLF) | 17-Aug-17 | Grant | 5,000,000 | $0.06 | $300,000.00 | 36% 13.7M to 18.7M | |
| 02-Mar-18 3:00 PM View: | Campbell Vyvyan Director | Petlife Pharmaceuticals, Inc. (PTLF) | 17-Aug-17 | Acquisition (other) | 1,000,000 | -- | -- | 50% 2.0M to 3.0M | |
| 02-Mar-18 3:00 PM View: | Salvagno Ralph T Chief Executive Officer Director 10% Owner | Petlife Pharmaceuticals, Inc. (PTLF) | 17-Aug-17 | Disposition (other) | 1,250,000 | -- | -- | (6%) 19.95M to 18.7M | |
| 02-Mar-18 3:00 PM View: | Vivek Ramana Chief Medical Officer | Petlife Pharmaceuticals, Inc. (PTLF) | 17-Aug-17 | Acquisition (other) | 1,000,000 | -- | -- | 50% 2.0M to 3.0M | |
| 02-Mar-18 3:00 PM View: | Campbell Vyvyan Director | Petlife Pharmaceuticals, Inc. (PTLF) | 17-Aug-17 | Disposition (other) | 1,000,000 | -- | -- | (33%) 3.0M to 2.0M | |
| 24-Mar-17 7:47 PM View: | Campbell Vyvyan Director 10% Owner | Petlife Pharmaceuticals, Inc. (PTLF) | 23-Feb-17 | Private Purchase | 40,000 | $0.25 | $10,000.00 | < 1% 11.05M to 11.09M | |
| 24-Mar-17 7:47 PM View: | Campbell Vyvyan Director 10% Owner | Petlife Pharmaceuticals, Inc. (PTLF) | 23-Feb-17 | Grant | 9,484,560 | $0.50 | $4,742,280.00 | 605% 1.57M to 11.05M | (60%) |
| 27-Mar-17 6:15 AM View: | Salvagno Ralph T Chief Executive Officer Director | Petlife Pharmaceuticals, Inc. (PTLF) | 23-Feb-17 | Grant | 11,160,000 | $0.50 | $5,580,000.00 | 979% 1.14M to 12.3M | (60%) |
| 02-Mar-18 3:00 PM View: | Vivek Ramana Chief Medical Officer | Petlife Pharmaceuticals, Inc. (PTLF) | 27-Oct-16 | Grant | 1,000,000 | $0.67 | $670,000.00 | 100% 1000.0K to 2.0M | (62%) |
| 24-Mar-17 7:47 PM View: | Campbell Vyvyan Director 10% Owner | Petlife Pharmaceuticals, Inc. (PTLF) | 27-Oct-16 | Grant | 1,200,000 | $0.50 | $600,000.00 | 325% 368.68K to 1.57M | |
| 24-Mar-17 7:47 PM View: | Campbell Vyvyan Director 10% Owner | Petlife Pharmaceuticals, Inc. (PTLF) | 15-May-16 | Purchase | 218,470 | $1.25 | $273,088.00 | 145% 150.21K to 368.68K | |
| 27-Mar-17 6:15 AM View: | Salvagno Ralph T CEO Director 10% Owner | Petlife Pharmaceuticals, Inc. (PTLF) | 12-Feb-16 | Purchase | 1,040,000 | $0.55 | $568,400.00 | 1040% 100.0K to 1.14M | |
| 27-Mar-17 6:15 AM View: | Salvagno Ralph T CEO Director 10% Owner | Petlife Pharmaceuticals, Inc. (PTLF) | 29-Dec-15 | Purchase | 100,000 | $0.25 | $25,000.00 | 100% 0 to 100.0K | |
| 24-Mar-17 7:47 PM View: | Campbell Vyvyan Director 10% Owner | Petlife Pharmaceuticals, Inc. (PTLF) | 09-Nov-15 | Purchase | 100,000 | $0.25 | $25,000.00 | 199% 50.21K to 150.21K | |
| 24-Mar-17 7:47 PM View: | Campbell Vyvyan Director 10% Owner | Petlife Pharmaceuticals, Inc. (PTLF) | 30-May-15 | Purchase | 50,210 | $0.75 | $37,657.50 | 100% 0 to 50.21K | |
| 18-Dec-07 12:15 PM View: | White Curt C | Petlife Pharmaceuticals, Inc. (PTLF) | 13-Dec-07 | Sale | 13,000,000 | $0.00 | $5,200.00 | (95%) 13.75M to 750.0K |
